Zhang M L, Sugawa H, Kosugi S, Mori T
Department of Laboratory Medicine, Kyoto University School of Medicine, Japan.
Biochem Biophys Res Commun. 1995 Jun 6;211(1):205-10. doi: 10.1006/bbrc.1995.1797.
Mutations involving the transmembrane domain of the thyrotropin receptor (TSHR) confer constitutive activation of the receptor and can cause human diseases. Naturally occurring activating mutations identified to date are located only in the transmembrane domain of the receptor. We now report a mutant involving the extracellular domain of the TSHR which also shows constitutive activation. This mutation is missing residues 339-367 located in the C-terminal portion of the extracellular domain. When expressed in COS-7 cells, the mutated TSHR (M3B) retained similar TSH binding ability to that of the wild-type receptor. However, the basal cAMP production without TSH stimulation in COS-7 cells transfected with M3B cDNA was significantly higher than that of COS-7 cells with wild-type receptor, indicating that the mutant receptor is constitutively activated. Our results provide new insight into the mechanism of receptor activation.
涉及促甲状腺激素受体(TSHR)跨膜结构域的突变会导致该受体的组成性激活,并可引发人类疾病。迄今为止鉴定出的天然存在的激活突变仅位于受体的跨膜结构域。我们现在报告一种涉及TSHR细胞外结构域的突变体,该突变体也表现出组成性激活。此突变缺失位于细胞外结构域C末端部分的339 - 367位残基。当在COS - 7细胞中表达时,突变的TSHR(M3B)保留了与野生型受体相似的促甲状腺激素结合能力。然而,用M3B cDNA转染的COS - 7细胞在无促甲状腺激素刺激时的基础cAMP产生量显著高于转染野生型受体的COS - 7细胞,这表明突变受体被组成性激活。我们的结果为受体激活机制提供了新的见解。